NCT02989649View on ClinicalTrials.gov

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

TerminatedOBSERVATIONAL
Enrollment

593

Participants

Timeline

Start Date

December 22, 2016

Primary Completion Date

January 26, 2018

Study Completion Date

January 26, 2018

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Alogliptin

Alogliptin tablets

DRUG

Alogliptin FDC With Pioglitazone

Alogliptin FDC with pioglitazone tablets

DRUG

Alogliptin FDC With Metformin

Alogliptin FDC with metformin tablets

Trial Locations (11)

Unknown

Beijing

Wuhan

Dalian

Shenyang

Jinan

Qingdao

Taian

Tai’an

Tianjin

Sai Ying Pun

Shatin

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY